Skip to content

Latest commit

 

History

History
54 lines (43 loc) · 2.45 KB

CHANGELOG.md

File metadata and controls

54 lines (43 loc) · 2.45 KB

CHANGELOG

[1.0] 2021-04-09

First public release. Here are the changes compared with the last early-access release version 0.4.2.

  • Updated the CMAC core version check to be compatiable with Vivado 2020.2.
  • Added randomization of MAC address generation.
  • Enabled RS-FEC support.
  • Adjusted the waiting time for RX lane alignment.
  • Disabled TX completion interrupt and move the completion routine into a couple of different contexts.

Copyright Notice and Disclaimer

This file contains confidential and proprietary information of Xilinx, Inc. and is protected under U.S. and international copyright and other intellectual property laws.

DISCLAIMER

This disclaimer is not a license and does not grant any rights to the materials distributed herewith. Except as otherwise provided in a valid license issued to you by Xilinx, and to the maximum extent permitted by applicable law: (1) THESE MATERIALS ARE MADE AVAILABLE "AS IS" AND WITH ALL FAULTS, AND XILINX HEREBY DISCLAIMS ALL WARRANTIES AND CONDITIONS, EXPRESS, IMPLIED, OR STATUTORY, INCLUDING BUT NOT LIMITED TO WARRANTIES OF MERCHANTABILITY, NONINFRINGEMENT, OR FITNESS FOR ANY PARTICULAR PURPOSE; and (2) Xilinx shall not be liable (whether in contract or tort, including negligence, or under any other theory of liability) for any loss or damage of any kind or nature related to, arising under or in connection with these materials, including for any direct, or any indirect, special, incidental, or consequential loss or damage (including loss of data, profits, goodwill, or any type of loss or damage suffered as a result of any action brought by a third party) even if such damage or loss was reasonably foreseeable or Xilinx had been advised of the possibility of the same.

CRITICAL APPLICATIONS

Xilinx products are not designed or intended to be fail-safe, or for use in any application requiring failsafe performance, such as life-support or safety devices or systems, Class III medical devices, nuclear facilities, applications related to the deployment of airbags, or any other applications that could lead to death, personal injury, or severe property or environmental damage (individually and collectively, "Critical Applications"). Customer assumes the sole risk and liability of any use of Xilinx products in Critical Applications, subject only to applicable laws and regulations governing limitations on product liability.

THIS COPYRIGHT NOTICE AND DISCLAIMER MUST BE RETAINED AS PART OF THIS FILE AT ALL TIMES.